Novel Vaccine Developments for Feline Herpesvirus 1 (FHV1), Calicivirus (FCV), and Panleukopenia Virus (FPV)

A world‑leading animal health company is seeking research related to developing novel vaccines for feline herpesvirus 1 (FHV1), feline calicivirus (FCV), and feline panleukopenia virus (FPV). Specifically, they are interested in live vaccines with the ability to replicate, with a focus on live-attenuated vaccines and viral vector vaccines. The team are also interested in vaccine delivery methods as an alternative to injection (e.g. oral, nasal, tablet, topical, or spray form) that may be preferable for pets and their owners.

For this campaign, our client is focusing on engaging with relevant research, technologies and experts in China and Hong Kong.

Approaches of Interest:

• Live-attenuated vaccines
• Viral vector vaccines (including recombinant)
• Alternative vaccine administration methods e.g. intranasal, oral 

Out of Scope:

• Vaccines based on inactivated viral antigens
• mRNA or protein subunit based vaccines

Developmental Stages of Interest:

• Research with in vitro validation or proof of concept are preferred. Early stage research with clear application to the pathogens is also of interest
• Our client is interested in engaging with researchers with expertise in vaccine development that can be applied to feline herpesvirus 1 (FHV1), feline calicivirus (FCV), and feline panleukopenia virus (FPV)

Submission Information

Submission of one page, 200-300 word briefs are encouraged, along with any optional supplementary information e.g. relevant publications. Our client is also open to receiving proposals for novel research projects using this application form. In submitting to this campaign, you confirm that your submission contains only non-confidential information.

Opportunity for Collaboration

Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Example outcomes include licensing assets, ongoing research collaboration, support funding for promising research in the region of $100k USD and above per year. Our client also has local research resources available in China that may form part of collaborations and support for researchers.